ArticleJournal of thrombosis and thrombolysis2026

Comparison of activated and 4-factor prothrombin complex concentrates for reversal of apixaban- and rivaroxaban-associated major bleeding.

R Monroe Crawley et al.PubMed ↗Publisher ↗

No numbers read from the abstract.